Is Intentional Continuous Shallowing of the Anterior Chamber (ICSAC) a safe procedure? Does it cause endothelial cell damage?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26827

Enrollment

Registered

2011-08-26

Start date

2011-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular pucker, macular hole and vitreous opacities requiring vitrectomy.

Interventions

Vitrectomy with ICSAC versus vitrectomy without ICSAC.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age ¡Ý 18 years; 2. Informed consent; 3. Requiring vitrectomy for floaters, macular pucker or macular hole.

Exclusion criteria

Exclusion criteria: 1. Vitrectomy procedure is anticipated to be complicated; 2. ECD < 2000 mm-2; 3. Pseudophakia.

Design outcomes

Primary

Measure	Time frame
Endothelial cell density (ECD) at 1 and 3 months.	—

Secondary

Measure	Time frame
1. ECD at 6 months; 2. Anterior Chamber Depth at 3 and 6 months; 3. Corneal Topography at 3 and 6 months; 4. Best corrected visual acuity; 5. Intraocular pressure; 6. Gonioscopy; 7. Complications (retinal defects, retinal detachment, etc.).	—

Contacts

Public ContactJ.C. Meurs, van

Oogziekenhuis Rotterdam, Schiedamsevest 180

vanMeurs@oogziekenhuis.nl+31 (0)10 4017777

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)